We demonstrated that in this population, elevated adiponectin and NT-proBNP were positively associated with increased risk for HF hospitalization and CVD mortality despite a more favorable cardiometabolic profile, including less diabetes and obesity. The gene discussed is ADIPOQ; the disease is obesity disorder.